SCP Vitalife Partners — 2014 Investments

1 investments dated 2014 · listed companies and verified rows first · show all

Avedroavedro.comin 𝕏Nov 2014

Glaukos develops surgical and pharmaceutical therapies for ophthalmic diseases including glaucoma, corneal health, and retinal disease.

BiotechHealthtechMedical DevicesWaltham, US

Jason Hong(Director)David F. Muller(Executive Officer, Director)Robert Palmisano(Director)Philip J. Ferneau(Director)M. Carl Johnson, III(Director)David Berry(Director)

Board seatJeff Dykan· per SEC Form D

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.